Augmentation of myocardial I<sub>f</sub> dysregulates calcium homeostasis and causes adverse cardiac remodeling.

Yampolsky, Pessah; Koenen, Michael; Mosqueira, Matias; Geschwill, Pascal; Nauck, Sebastian; Witzenberger, Monika; Seyler, Claudia; Fink, Thomas et al. · Nat Commun · 2019

basic_science · Level V

Where this comes from

Abstract

HCN channels underlie the depolarizing funny current (I<sub>f</sub>) that contributes importantly to cardiac pacemaking. I<sub>f</sub> is upregulated in failing and infarcted hearts, but its implication in disease mechanisms remained unresolved. We generated transgenic mice (HCN4<sup>tg/wt</sup>) to assess functional consequences of HCN4 overexpression-mediated I<sub>f</sub> increase in cardiomyocytes to levels observed in human heart failure. HCN4<sup>tg/wt</sup> animals exhibit a dilated cardiomyopathy phenotype with increased cellular arrhythmogenicity but unchanged heart rate and conduction parameters. I<sub>f</sub> augmentation induces a diastolic Na<sup>+</sup> influx shifting the Na<sup>+</sup>/Ca<sup>2+</sup> exchanger equilibrium towards 'reverse mode' leading to increased [Ca<sup>2+</sup>]<sub>i</sub>. Changed Ca<sup>2+</sup> homeostasis results in significantly higher systolic [Ca<sup>2+</sup>]<sub>i</sub> transients and stimulates apoptosis. Pharmacological inhibition of I<sub>f</sub> prevents the rise of [Ca<sup>2+</sup>]<sub>i</sub> and protects from ventricular remodeling. Here we report that augmented myocardial I<sub>f</sub> alters intracellular Ca<sup>2+</sup> homeostasis leading to structural cardiac changes and increased arrhythmogenicity. Inhibition of myocardial I<sub>f</sub> per se may constitute a therapeutic mechanism to prevent cardiomyopathy.

Medical subject headings